This episode currently has no reviews.
Submit ReviewSome Boston-area researchers said the decision by advisors to the U.S. Food and Drug Administration reflected challenges facing regulators as psychedelic treatments enter mainstream psychiatry.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review